Malta - angleščina - Medicines Authority

cande s.r.o. e. belluša 6752/4, piešany 92101, slovakia - dutasteride, tamsulosin hydrochloride - hard capsule - dutasteride 0.5 mg tamsulosin hydrochloride 0.4 mg - urologicals

Malta - angleščina - Medicines Authority

pharmaceutical works polpharma sa 19 pelplinska steet, 83-200 starogard gdanski, poland - dutasteride, tamsulosin hydrochloride - hard capsule - tamsulosin hydrochloride 0.4 mg dutasteride 0.5 mg - urologicals

Irska - angleščina - HPRA (Health Products Regulatory Authority)

pinewood laboratories ltd - dutasteride; tamsulosin hydrochloride - capsule, hard - 0.5 mg/0.4 milligram(s) - tamsulosin and dutasteride

Združene države Amerike - angleščina - NLM (National Library of Medicine)

actavis pharma, inc. - dutasteride (unii: o0j6xjn02i) (dutasteride - unii:o0j6xjn02i), tamsulosin hydrochloride (unii: 11sv1951mr) (tamsulosin - unii:g3p28oml5i) - dutasteride 0.5 mg - dutasteride and tamsulosin hydrochloride capsules are indicated for the treatment of symptomatic bph in men with an enlarged prostate. dutasteride-containing products, including dutasteride and tamsulosin hydrochloride capsules, are not approved for the prevention of prostate cancer. dutasteride and tamsulosin hydrochloride capsules are contraindicated for use in: - pregnancy. in animal reproduction and developmental toxicity studies, dutasteride inhibited development of male fetus external genitalia. therefore, dutasteride and tamsulosin hydrochloride capsules may cause fetal harm when administered to a pregnant woman. if dutasteride and tamsulosin hydrochloride capsules are used during pregnancy, or if the patient becomes pregnant while taking dutasteride and tamsulosin hydrochloride capsules, the patient should be apprised of the potential hazard to the fetus [see warnings and precautions (5.6), use in specific populations (8.1)] . - women of childbearing potential [see warnings and precautions (5.6), use

Irska - angleščina - HPRA (Health Products Regulatory Authority)

mcdermott laboratories ltd., t/a gerard laboratories - dutasteride; tamsulosin hydrochloride - capsule, hard - 0.5 mg/0.4 milligram(s) - alpha-adrenoreceptor antagonists; tamsulosin and dutasteride

Irska - angleščina - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - dutasteride; tamsulosin hydrochloride - capsule, hard - 0.5 mg/0.4 milligram(s) - alpha-adrenoreceptor antagonists; tamsulosin and dutasteride

Avstralija - angleščina - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - dutasteride, quantity: 500 microgram; tamsulosin hydrochloride, quantity: 400 microgram - capsule, modified release - excipient ingredients: maize starch; carrageenan; gelatin; purified talc; butylated hydroxytoluene; iron oxide yellow; titanium dioxide; iron oxide red; glycerol; medium chain triglycerides; potassium chloride; microcrystalline cellulose; methacrylic acid - ethyl acrylate copolymer (1:1); purified water; triethyl citrate; lecithin; glyceryl caprylate/caprate; sunset yellow fcf; carnauba wax; hypromellose; propylene glycol; ethanol; butan-1-ol; isopropyl alcohol; shellac; iron oxide black; simethicone; strong ammonia solution; potassium hydroxide - duodart is indicated for the management of moderate to severe symptomatic benign prostatic hyperplasia (bph).

Malta - angleščina - Medicines Authority

galenicum health, s.l. - dutasteride, tamsulosin hydrochloride - hard capsule - dutasteride 0.5 milligram(s) ; tamsulosin hydrochloride 0.4 milligram(s) - urologicals

Malta - angleščina - Medicines Authority

galenicum health, s.l. - dutasteride, tamsulosin hydrochloride - hard capsule - dutasteride 0.5 milligram(s) ; tamsulosin hydrochloride 0.4 milligram(s) - urologicals

Malta - angleščina - Medicines Authority

uropharm ag - dutasteride, tamsulosin hydrochloride - hard capsule - dutasteride 0.5 milligram(s) ; tamsulosin hydrochloride 0.4 milligram(s) - urologicals